Report ID |
2761 |
Drug Identification Number |
02212358 |
Brand name |
ZANTAC |
Common or Proper name |
Ranitidine tablets |
Company Name |
GLAXOSMITHKLINE INC |
Market Status |
CANCELLED POST MARKET |
Active Ingredient(s) |
RANITIDINE |
Strength(s) |
300MG |
Dosage form(s) |
TABLET |
Route of administration |
ORAL |
Packaging size |
60's |
ATC code |
A02BA |
ATC description |
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage |
Disruption of the manufacture of the drug. |
Anticipated start date |
|
Actual start date |
2017-04-19 |
Estimated end date |
|
Actual end date |
2017-09-14 |
Shortage status |
Resolved |
Updated date |
2020-02-27 |
Company comments |
This product has been discontinued. |
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
1-800-387-7374 |